Headline News about CymaBay Therapeutics Inc. - Common Stock





Dow Surges Over 150 Points; Gilead Sciences To Acquire CymaBay Therapeutics For $4.3B
February 12, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities

6 Analysts Have This to Say About CymaBay Therapeutics
December 15, 2023
Via Benzinga

Recap: CymaBay Therapeutics Q3 Earnings
November 07, 2023
Via Benzinga

Dow Up Triple Digits, Hits Fresh Highs
February 12, 2024
Via Talk Markets


CymaBay Therapeutics, ContextLogic, Snap And Other Big Stocks Moving Higher On Monday
February 12, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities

Via Benzinga

Earnings Outlook For CymaBay Therapeutics
November 06, 2023
Via Benzinga

Where CymaBay Therapeutics Stands With Analysts
November 06, 2023
Via Benzinga


Drugmaker Gilead Sciences Scoops Up Liver-Disease Focused CymaBay Therapeutics For $4.3B
February 12, 2024
Via Benzinga
Exposures
Product Safety






Via Benzinga

Investors Eye CymaBay's AFFIRM Study As Regulatory Uncertainties Ease
September 21, 2023
Via Benzinga






Smartsheet, Kroger, Lantronix And Other Big Stocks Moving Higher On Friday
September 08, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities


12 Health Care Stocks Moving In Thursday's Pre-Market Session
September 07, 2023
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.